 |
 |
Hi folks, Do we put up with Cabergoline not being available in the USA?? My caregiver said, how about a class-action lawsuit against Upjohn? They should not hold Cabergoline hostage! Or is it the FDA that should be sued? ^^^^^^WARM GREETINGS FROM^^^^^^^^^^^^^^^^^ Ivan Suzman 48/12 [log in to unmask] Portland, Maine Land of lighthouses deg. F ******************************************************************** On Sun, 23 Aug 1998 08:01:22 -0700 "J. R. Bruman" <[log in to unmask]> writes: >[log in to unmask] wrote: >> >> Hi again >> As the resident cabergoline trial person on the list (I think I >recall only >> one other person ever responding to the list re: cabergoline >> dosage)..........I will comment here. >>Although I would have stomped on whoever made the decision to >withdraw the >> cabergoline at the time I learned it would end for Parkinson's >> patients...........a year later I will FIRMLY STATE.......I am glad >that I am >> not on cabergoline any longer. I cannot speak for all patients by >any means......but the switch to Mirapex as >> a drug with less side effects for me was a positive move. >-- >Rita, your point is well taken, and very likely Mirapex is better. But >we've seen comment by others here, who had to give up on Mirapex. It's >a reminder that individual tolerance of PD drugs is extremely variable >and "one's meat may be another's poison". So the more options kept >available, the better. Cheers, >Joe >J. R. Bruman (818) 789-3694 >3527 Cody Road >Sherman Oaks, CA 91403-5013 >